Loading
Latest filing published 07 Feb 2022 for Yumanity Therapeutics, INC., €3,171. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Paulash Mohsen in Kineta, Inc./de, where the filings describe the role as senior executive. Between 1 December 2021 and 3 February 2022, the trades on record add up to 2 filings.
Sales make up the whole of the open-market record (1 sale, €3,171). The rest of the record consists of 1 share grant. 2022 to date brings no purchases and 1 sale.
Most recently, on 7 February 2022, the filings show an open-market sale worth €3,171 in Kineta, Inc./de. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations